(NASDAQ: AHCO) Adapthealth's forecast annual revenue growth rate of 7.18% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Adapthealth's revenue in 2026 is $3,244,857,000.On average, 10 Wall Street analysts forecast AHCO's revenue for 2026 to be $480,730,704,192, with the lowest AHCO revenue forecast at $458,304,759,552, and the highest AHCO revenue forecast at $496,904,567,296. On average, 9 Wall Street analysts forecast AHCO's revenue for 2027 to be $514,029,834,112, with the lowest AHCO revenue forecast at $486,575,041,280, and the highest AHCO revenue forecast at $538,630,415,808.
In 2028, AHCO is forecast to generate $541,484,626,944 in revenue, with the lowest revenue forecast at $500,166,522,880 and the highest revenue forecast at $570,842,227,200.